Intravenous patient‐controlled analgesia using remifentanil in a child with Axenfeld‐Rieger syndrome*

Abstract

Patient-controlled analgesia (PCA) using intravenous opioids is increasing in popularity for children aged 5 years and over. To our knowledge there are no reports on the use of PCA in children with remifentanil in the postoperative period. We report successful use of remifentanil for intravenous (IV) PCA in a child scheduled for suprasellar arachnoid cystectomy with Axenfeld-Rieger syndrome who needed good postoperative analgesia because of accompanying serious problems.

Comparison of Remifentanil and Fentanyl for Postoperative Pain Control after Abdominal Hysterectomy

“…There are some articles that advocate favorable results of remifentanil infusion for postoperative pain,5,10-14 especially in critical patients,10,11,14 but the authors stopped the current study when 3 patients from the group R had serious respiratory depression.…”

“…Although there have been no studies so far about equipotent doses of fentanyl and remifentanil for postoperative pain control, fentanyl in this study was infused at the recommended basal infusion rate15 and remifentanil was also infused at the basal infusion rate known to be effective for postoperative pain control 5,11,12,14. Patient-controlled analgesia technique is more effective in cases of IV pain control, but our study used only basal infusion for fear that bolus doses of remifentanil might cause respiratory depression 5,16-19…”

Axenfeld-Rieger syndrome: A systematic review examining genetic, neurological, and neurovascular associations to inform screening

“… b The total number of studies and patients in this table is out of those that included genetic data, which excludes 14 studies [ 2 , 6 , 46 , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] ] without data and 2 studies [ 67 , 68 ] with no genetic abnormalities noted. …”